Edwards Lifesciences Cost Of Revenue Over Time
| EW Stock | USD 71.27 0.79 1.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Edwards Lifesciences Performance and Edwards Lifesciences Correlation. Edwards |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 7.161 | Earnings Share 2.62 | Revenue Per Share 10.498 | Quarterly Revenue Growth 0.089 | Return On Assets 0.1065 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cost Of Revenue Analysis
Compare Edwards Lifesciences Corp and related stocks such as Medtronic PLC, Abbott Laboratories, and Boston Scientific Corp Cost Of Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT | 117.5 M | 3.9 B | 4.1 B | 4.3 B | 6.3 B | 9.1 B | 9.3 B | 9.1 B | 9.2 B | 9.4 B | 10.5 B | 10.1 B | 10.7 B | 11.1 B | 11.6 B |
| ABT | 1.5 B | 15.5 B | 15.1 B | 10 B | 9.2 B | 8.7 B | 9 B | 12.3 B | 12.7 B | 13.2 B | 15 B | 18.5 B | 19.1 B | 18 B | 9.6 B |
| BSX | 78.4 M | 2.7 B | 2.5 B | 2.3 B | 2.3 B | 2.2 B | 2.5 B | 2.7 B | 2.9 B | 3.2 B | 3.5 B | 3.8 B | 4 B | 4.3 B | 4.6 B |
| ZBH | 265 M | 1.1 B | 1.1 B | 1.3 B | 1.2 B | 1.9 B | 2.4 B | 2.1 B | 2.3 B | 2.3 B | 2.1 B | 2 B | 2 B | 2.1 B | 1.4 B |
| SYK | 47.4 M | 2.8 B | 2.8 B | 3 B | 3.3 B | 3.3 B | 3.8 B | 4.3 B | 4.7 B | 5.2 B | 5.3 B | 6.1 B | 6.9 B | 7.4 B | 7.8 B |
| DXCM | 11 M | 40.4 M | 53.3 M | 59.9 M | 82.9 M | 123.6 M | 194.9 M | 226.4 M | 367.7 M | 544.5 M | 646.6 M | 768 M | 1 B | 1.3 B | 1.4 B |
| PODD | 1.5 M | 85.5 M | 119 M | 134.7 M | 145.4 M | 130.6 M | 155.9 M | 186.6 M | 193.7 M | 257.9 M | 322.1 M | 346.7 M | 499.7 M | 537.2 M | 564.1 M |
| TNDM | 3.8 M | 3.8 M | 3.8 M | 22.8 M | 34.5 M | 46.3 M | 60.7 M | 63.5 M | 94 M | 168.1 M | 238.3 M | 326.6 M | 388.2 M | 380 M | 399 M |
| ALGN | 1.8 M | 118.5 M | 143.7 M | 162.1 M | 183.2 M | 205.4 M | 264.6 M | 356.5 M | 518.6 M | 662.9 M | 708.7 M | 1 B | 1.1 B | 1.2 B | 1.2 B |
Edwards Lifesciences Corp and related stocks such as Medtronic PLC, Abbott Laboratories, and Boston Scientific Corp Cost Of Revenue description
Cost of Revenue is found on Edwards Lifesciences Corp income statement and represents the costs associated with goods and services Edwards Lifesciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.My Equities
My Current Equities and Potential Positions
| Edwards Lifesciences Corp | EW |
| Classification | Medical Equipment |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 71.27
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.